05:17 AM EDT, 05/14/2024 (MT Newswires) -- Belite Bio ( BLTE ) reported a Q1 net loss late Monday of $0.27 per ordinary share, compared with a loss of $0.33 per share a year earlier.

Four analysts polled by Capital IQ expected a loss of $0.29 per share.

The company did not report any revenue for the quarter ended March 31.

Total operating expenses were $8.3 million for the quarter, up from $6.9 million a year earlier.